GPT Healthcare Ltd
GPTHEALTH NSE
GPT Healthcare Ltd
Healthcare ServicesNSE: GPTHEALTH BSE: 544131 Hospitals
Key Fundamentals
MicrocapHospitalsHealthcare ServicesMarket Cap
₹1,238 Cr
Volatility
Moderate
P/E Ratio
26.22
EBITDA
₹78.80 Cr
Return on Equity
26.34%
Debt to Equity
0.34
Book Value
₹32.84
EPS
₹5.08
52W High
₹175
52W Low
₹115
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view GPT Healthcare Ltd insights
48 extracted metrics + investor summaries across FY20–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
1- Company has been maintaining a healthy dividend payout of 49.9%
Growth Rate
Revenue Growth
37.57% ↗
Net Income Growth
97.63% ↗
Cash Flow Change
53.50% ↗
ROE
67.13% ↗
ROCE
54.46% ↗
EBITDA Margin (Avg.)
3.97% ↘
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 96 | 108 | 97 | 99 | 98 | 106 | 102 | 101 | 107 | 119 | 120 | 126 | 126 |
| Expenses | 77 | 83 | 76 | 76 | 80 | 82 | 81 | 81 | 90 | 96 | 99 | 103 | 102 |
| Operating Profit | 19 | 25 | 21 | 23 | 18 | 23 | 21 | 21 | 17 | 23 | 21 | 23 | 24 |
| OPM % | 20% | 23% | 22% | 23% | 18% | 22% | 21% | 20% | 16% | 19% | 17% | 18% | 19% |
| Other Income | 1 | 1 | 1 | 2 | 2 | 3 | 2 | 2 | 2 | 1 | 1 | 2 | 2 |
| Interest | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| Depreciation | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 6 | 7 | 7 | 7 | 7 |
| PBT | 14 | 19 | 16 | 18 | 15 | 21 | 18 | 16 | 11 | 15 | 13 | 16 | 17 |
| Tax % | 30% | 31% | 28% | 30% | 32% | 28% | 30% | 21% | 31% | 30% | 27% | 8% | 26% |
| Net Profit | 10 | 14 | 11 | 13 | 10 | 15 | 12 | 13 | 8 | 11 | 9 | 15 | 13 |
| EPS in Rs | 1.25 | 1.69 | 1.44 | 1.56 | 1.21 | 1.81 | 1.49 | 1.57 | 0.94 | 1.29 | 1.14 | 1.78 | 1.55 |
Profit & Loss
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 212 | 243 | 337 | 361 | 400 | 407 | 473 | 492 |
| Expenses | 176 | 194 | 263 | 287 | 312 | 324 | 387 | 401 |
| Operating Profit | 36 | 49 | 74 | 74 | 88 | 83 | 85 | 91 |
| OPM % | 17% | 20% | 22% | 21% | 22% | 20% | 18% | 19% |
| Other Income | 4 | 6 | 5 | 6 | 5 | 8 | 5 | 6 |
| Interest | 14 | 14 | 11 | 9 | 7 | 3 | 8 | 9 |
| Depreciation | 11 | 12 | 14 | 15 | 18 | 19 | 27 | 28 |
| PBT | 15 | 29 | 54 | 56 | 68 | 69 | 55 | 61 |
| Tax % | 26% | 27% | 23% | 30% | 30% | 28% | 23% | — |
| Net Profit | 11 | 21 | 42 | 39 | 48 | 50 | 42 | 47 |
| EPS in Rs | 6.11 | 11.76 | 5.21 | 4.88 | 5.82 | 6.08 | 5.15 | 5.76 |
| Div. Payout % | 0% | 47% | 0% | 102% | 60% | 41% | 49% | — |
Balance Sheet
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 18 | 18 | 80 | 80 | 82 | 82 | 82 |
| Reserves | 109 | 116 | 78 | 85 | 136 | 166 | 187 |
| Borrowings | 157 | 166 | 102 | 82 | 31 | 35 | 91 |
| Other Liabilities | 25 | 18 | 63 | 79 | 96 | 101 | 104 |
| Total Liabilities | 308 | 317 | 323 | 327 | 346 | 384 | 465 |
| Fixed Assets | 226 | 220 | 220 | 228 | 224 | 228 | 342 |
| CWIP | 2 | 0 | 1 | 3 | 6 | 46 | 1 |
| Investments | 1 | 1 | 10 | 13 | 30 | 32 | 43 |
| Other Assets | 80 | 97 | 92 | 83 | 85 | 78 | 79 |
| Total Assets | 308 | 317 | 323 | 327 | 346 | 384 | 465 |
Cash Flow
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Operating | 41 | 43 | 66 | 66 | 69 | 67 | 81 |
| Investing | -54 | -16 | -5 | 5 | -25 | -33 | -47 |
| Financing | 12 | -22 | -57 | -73 | -48 | -35 | -31 |
| Net Cash Flow | -1 | 4 | 3 | -2 | -5 | 0 | 2 |
| Free Cash Flow | -5 | 38 | 59 | 58 | 50 | 18 | 40 |
| CFO/OP | 116 | 88 | 107 | 103 | 95 | 101 | 110 |
Ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 30 | 26 | 15 | 21 | 22 | 18 | 16 |
| Inventory Days | 60 | 41 | 30 | 43 | 36 | 41 | 43 |
| Days Payable | 314 | 165 | 121 | 161 | 165 | 161 | 170 |
| Cash Conversion Cycle | -224 | -98 | -76 | -97 | -106 | -102 | -112 |
| Working Capital Days | -4 | 32 | 3 | -18 | -16 | -28 | -29 |
| ROCE % | — | 14% | 23% | 25% | 30% | 27% | 20% |
Documents
1
Board Meeting Intimation for Approval Of Audited Results And Recommendation Of Final Dividend, If Any.
11h - Board meets May 18, 2026 to approve audited Q4/FY26 results and consider final dividend. 11h - Board meets May 18, 2026 to approve audited Q4/FY26 results and consider final dividend.
2
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
10h - Of earnings call for the 4th quarter and financial year ended March 31, 2026. 10h - Of earnings call for the 4th quarter and financial year ended March 31, 2026.
3
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
10 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026; no demat/remat requests received. 10 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026; no demat/remat requests received.
4
Announcement under Regulation 30 (LODR)-Change in Management
2 Apr - Debashis Dhar resigned as Senior VP and Chief Business Development Officer, effective April 2, 2026. 2 Apr - Debashis Dhar resigned as Senior VP and Chief Business Development Officer, effective April 2, 2026.
Frequently Asked Questions about GPT Healthcare Ltd
What does GPT Healthcare Ltd do?
Incorporated in 1989, GPT Healthcare Ltd is engaged in running hospitals and providing medical services[1]
Where is GPT Healthcare Ltd (GPTHEALTH) listed?
GPT Healthcare Ltd is listed on the Indian stock exchanges. It is listed on NSE: GPTHEALTH and BSE: 544131. You can view its live share price, financials, and ratios on Tapetide.
Which sector does GPT Healthcare Ltd belong to?
GPT Healthcare Ltd operates in the Healthcare Services sector within the Hospitals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of GPT Healthcare Ltd?
GPT Healthcare Ltd has a market capitalisation of approximately ₹1238.37 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of GPT Healthcare Ltd?
The Price-to-Earnings (PE) ratio of GPT Healthcare Ltd is 26.22. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of GPT Healthcare Ltd?
Over the past 52 weeks, GPT Healthcare Ltd has traded between a low of ₹115 and a high of ₹175. This range helps investors understand the stock's price volatility and recent trading levels.
Does GPT Healthcare Ltd pay dividends?
Yes, GPT Healthcare Ltd has a dividend yield of 1.65%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of GPT Healthcare Ltd?
GPT Healthcare Ltd has a Return on Equity (ROE) of 26.34%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research GPT Healthcare Ltd on Tapetide?
On Tapetide, you can view GPT Healthcare Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Incorporated in 1989, GPT Healthcare Ltd is engaged in running hospitals and providing medical services[1]
Website ilshospitals.com
CEO Dr. Om Prakash Tantia
Employees 1,924
Listed 2024-02-29
Face Value ₹ 10
Issued Size 8,20,54,823